Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)
14/06/2013
Conference Paper
Authors:
Matthews, A.;
Hu, L.;
Lu, L.;
Van Veldhuisen, P.
Secondary:
College on Problems of Drug Dependence Meeting
Location: San Diego, CA
URL:
http://www.cpdd.vcu.edu/index.html
Abstract:
{Aims: Though behavioral and pathological similarities between binge eating disorder and substance use disorders are known to researchers, associations between them are poorly studied. We compared pre-treatment BMI in substance users from 7 NIDA CTN clinical trials with that for age, race and gender comparable participants from the National Health and Nutrition Examination Survey (NHANES). Methods: Standardized Prevalence Ratio (SPR) of obesity (BMI&30kg/m2) was estimated and adjusted for age, gender, and race. ANOVA test was used to compare adjusted mean BMI. Cigarette smoking status was also adjusted for in a subset of participants with available data. Results: CTN participants had lower BMI (N=2017
